Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: From the signature of specific disease subsets to the identification of markers with prognostic relevance

Journal of Translational Medicine

Volumn 4, Issue , 2006, Pages

  Zucchetto, Antonella ^a   Sonego, Paolo ^a   Degan, Massimo ^a   Bomben, Riccardo ^a   Dal Bo, Michele ^a   Bulian, Pietro ^a   Benedetti, Dania ^a   Rupolo, Maurizio ^a   Del Poeta, Giovanni ^b   Campanini, Renato ^c   Gattei, Valter ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA3 INTEGRIN; ALPHA4 INTEGRIN; ALPHA5 INTEGRIN; BETA1 INTEGRIN; CD20 ANTIGEN; CD23 ANTIGEN; CD38 ANTIGEN; CD79B ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN V; INTERCELLULAR ADHESION MOLECULE 1; MEMBRANE ANTIGEN; PADGEM PROTEIN; PROTEIN KINASE ZAP 70; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; B CELL LEUKEMIA; CLINICAL PRACTICE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ALGORITHM; HUMAN; IMMUNOPHENOTYPING; METHODOLOGY; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; REFERENCE VALUE; REVIEW; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

EID: 33646241082     PISSN: 14795876     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-4-11     Document Type: Review

References (72)

1. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F: A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981, 48:198-206.
2. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS: Clinical staging of chronic lymphocytic leukemia. Blood 1975, 46:219-234.
3. Gattei V, Degan M, Gloghini A, De Iuliis A, Improta S, Rossi FM, Aldinucci D, Perin V, Serraino D, Babare R, Zagonel V, Gruss HJ, Carbone A, Pinto A: CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. Blood 1997, 89:2048-2059.
4. Shanafelt TD, Geyer SM, Kay NE: Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood 2003, 103:1202-1210.
5. Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P, Dohner H, Stilgenbauer S: VH mutational status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002, 1000:1410-1416.
6. Chiorazzi N, Ferrarini M: Chronic lymphocytic leukemia: lessons learned from studies ofthe B cell antigen receptor. Annu Rev Immunol 2003, 21:841-894,
7. Oscier DG, Thompsett A, Zhu D, Stevenson FK: Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood 1997, 89:4153-4160.
8. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N: Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94:1840-7.
9. Hamblin T, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK, Oscier DG: CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002, 99:1023-9.
10. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO, Staudt LM: Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001, 194:1639-1647.
11. Klein U, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, A. F, Inghirami G, Cro L, Baldini L, Neri A, Califano A, Dalla-Favera R: Gene expression profiling of B chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001, 194:1625-1638.
12. Stratowa C, Loffler G, Lichter P, Stilgenbauer S, Haberl P, Schweifer N, Dohner H, Wilgenbus KK: CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int J Cancer 2001, 91:474-80.
13. Jelinek DF, Tschumper RC, Stolovitzky GA, Iturria SJ, Tu Y, Lepre J, Shah N, Kay NE: Identification of a global gene expression signature of B-chronic lymphocytic leukemia. Mol Cancer Res 2003, 1:346-61.
14. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marce S, Lopez-Guillermo A, Campo E, Montserrat E: ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003, 348:1764-75.
15. Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG: ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004, 363:105-11.
16. Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, Neuberg DS, Flinn IW, Rai KR, Byrd JC, Kay NE, Greaves A, Weiss A, Kipps TJ: ZAP-70 compared with immunogiobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004, 351:893-901.
17. Zucchetto A, Sonego P, Degan M, Bomben R, Bo MD, Russo S, Attadia V, Rupolo M, Buccisano F, Principe MI, Poeta GD, Pucillo C, Colombatti A, Campanini R, Gattei V: Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling. J Cell Physiol 2004, 204:123.
18. Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Russo S, Attadia V, Rupolo M, Buccisano F, Steffan A, Del Poeta G, Pucillo C, Colombatti A, Campanini R, Gattei V: Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance. J Immunol Methods 2005, 305:20-32.
19. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95:14863-8.
20. Tibshirani R, Hastie T, Narasimhan B, Chu G: Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 2002, 99:6567-72.
21. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC, Golub TR: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002, 8:68-74.
22. Zucchetto A, Bomben R, Dal Bo M, Sonego P, Nanni P, Rupolo M, Bulian P, Benedetti D, Dal Maso L, Campanini R, Gattei V: A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia. J Cell Physiol 2005.
23. Brown M, Wittwer C: Flow cytometry: principles and clinical applications in hematology. Clin Chem 2000, 46:1221-1229.
24. Del Poeta G, Maurillo L, Veditti A, Buccisano F, Epiceno AM, Capelli G, Tamburini A, Suppo G, Battaglia A, Del Principe MI, Del Moro B, Masi M, Amadori S: Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood 2001, 98:2633-9.
25. Degan M, Rupolo M, Dal Bo M, Stefanon A, Bomben R, Zucchetto A, Canton E, Berretta M, Nanni P, Steffan A, Ballerini PF, Damiani D, Pucillo C, Attadia V, Colombatti A, Gattei V: Mutational status of IgVH genes consistent with antigen-driven selection but not percent of mutations has prognostic impact in B-cell chronic lymphocytic leukemia. Clin Lymphoma 2004, 5:123-126.
26. De Zen L, Bicciato S, te Kronnie G, Basso G: Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification. Leukemia 2003, 17:1557-65.
27. Golay J, Lazzari M, Facchinetti V, Bernasconi S, Borleri G, Barbui T, Rambaldi A, Introna M: CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59. Blood 2001, 98:3383-9.
28. Degan M, Bomben R, Dal Bo M, Zucchetto A, Nanni P, Rupolo M, Steffan A, Attadia V, Ballerini PF, Damiani D, Pucillo C, Del Poeta G, Colombatti A, Gattei V: Analysis of IgVH gene mutations in B-CLL according to antigen-driven selection identifies sub-groups with different prognosis and usage of the canonical SHM machinery. Br J Haematol 2004, 126:29-42.
29. [http://www-stat.stanford.edu/~tibs/PAM].
30. [http://bonsai.ims.u-tokyo.ac.ip/~mdehoon/software/cluster].
31. [http://sourceforge.net/projects/jtreeview/].
32. Maynadié M, Picard F, Husson B, Chatelain B, Cornet Y, Le Roux G, Campos L, Dromelet A, Lepelley P, Jouault H, Imbert M, Rosenwadj M, Verge V, Bissieres P, Raphael M, Bene MC, Feuillard J, (GEIL) GdIdL: Immunophenotypic clustering of myelodysplastic syndromes. Blood 2002, 100:2349-56.
33. Gattei V, Zucchetto A, Russo S, Stefanon A, Bomben R, Dal Bo M, et al.: Immunophenotypic clustering of B-CLL identifies subsets with different prognosis without a strict correlation with IgVH mutational status and CD38 expression. Blood 2003, 102:667a. Ref Type: Abstract
34. Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, et al.: Leucocyte Typing V Oxford: University Press; 1995.
35. Ringner M, Peterson C: Microarray-based cancer diagnosis with artificial neural networks. Biotechniques 2003:30-35.
36. Armitage P, Berry G: Statistical methods in medical research London: Blackwell Scientific; 1987.
37. Sherlock G: Analysis of large-scale gene expression data. Curr Opin Immunol 2000, 12:201-5.
38. Likas A, Vlassisb N, Verbeekb JJ: The global k-means clustering algorithm. Pattern Recognition 2003, 36:451-461.
39. Spath H: Cluster analysis algorithms Malabar, Florida: R.E.Krieger Publishing; 1980.
40. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK: Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999, 94:1848-1854.
41. Maloum K, Davi F, Merle-Beral H, Pritsch O, Magnac C, Vuillier F, Dighiero G, Troussard X, Mauro FF, Benichou J: Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood 2000, 96:377-379.
42. Lin K, Sherrington PD, Dennis M, Matrai Z, Cawley JC, Pettitt AR: Relationship between p53 dysfunction, CD38 expression, and IgVH mutation in chronic lymphocytic leukemia. Blood 2002, 1000:1404-1409.
43. Gu B, Dao LP, Wiley J: Impaired transendothelial migration of B-CLL lymphocytes: a defect linked to low L-selectin expression. Leuk Lymphoma 2001, 42:5-12.
44. Lane PJ, McConnell FM, Clark EA, Mellins E: Rapid signaling to B cells by antigen-specific T cells requires CD18/CD54 interaction. J Immunol 1991, 147:4103-8.
45. Ley K: Integration of inflammatory signals by rolling neutrophils. Immunol Rev 2002, 186:8-18.
46. Mills DM, Cambier JC: B lymphocyte activation during cognate interactions with CD4+ T lymphocytes: molecular dynamics and immunologic consequences. Semin Immunol 2003, 15:325-9.
47. Poudrier J, Owens T: CD54/intercellular adhesion molecule I and major histocompatibility complex II signaling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation. J Exp Med 1994, 179:1417-27.
48. Chang B, Casali P: The CDRI sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today 1994, 15:367-373.
49. Lossos IS, Tibshirani R, Narasimhan B, Levy R: The inference of antigen selection on Ig genes. J Immunol 2000, 165:5122-5126.
50. Dorner T, Foster SJ, Brezinschek HP, Lipsky PE: Analysis of the hypermutational machinery and the impact of subsequent selection on the distribution of nucleotide changes in human VHDJH rearrangements. Immunol Rev 1998, 162:161-171.
51. Pittner BT, Shanafelt TD, Kay NE, Jelinek DF: CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation. Leukemia 2005, 19:2264-2272.
52. Zucchetto A, Bomben R, Dal Bo M, Bulian P, Benedetti D, Nanni P, Del Poeta G, Degan M, Gattei V: CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance. Leukemia 2006.
53. Eksioglu-Demiralp E, Alpdogan O, Aktan M, Firatli T, Ozturk A, Budak T, Bayik M, Akoglu T: Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages. Leukemia 1996, 10:1331-9.
54. de la Fuente MT, Casanova B, Garcia-Gila M, Silva A, Garcia-Pardo A: Fibronectin interaction with alpha4betal integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bc1-2 and Bax. Leukemia 1999, 13:266-74.
55. de la Fuente MT, Casanova B, Moyano JV, Garcia-Gila M, Sanz L, Garcia-Marco J, Silva A, Garcia-Pardo A: Engagement of alpha4beta I integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine. J Leukoc Biol 2002, 71:495-502.
56. de la Fuente MT, Casanova B, Cantero E, Hernandez del Cerro M, Garcia-Marco J, Silva A, Garcia-Pardo A: Involvement of p53 in alpha4beta I integrin-mediated resistance of B-CLL cells to fludarabine. Biochem Biophys Res Commun 2003, 311:708-12.
57. Stevenson FK, Caligaris-Cappio F: Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 2004, 103:4389-4395.
58. Cox DR: Regression models and life-tables. J R Stat Soc 1972, 34:187-220.
59. Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, Levy R: Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 2004, 350:1828-1837.
60. Tedder TF, Matsuyama T, Rothstein D, Schlossman SF, Morimoto C: Human antigen-specific memory T cells express the homing receptor (LAM-1) necessary for lymphocyte recirculation. Eur J Immunol 1990, 20:1351-5.
61. Hothorn T, Lausen B: On the Exact Distribution of Maximally Selected Rank Statistics. Computational Statistics & Data Analysis 2003, 43:121-137.
62. [http://www.r-project.org/].
63. Bomben R, Dal Bo M, Zucchetto A, Zaina E, Nanni P, Sonego P, Del Poeta G, Degan M, Gattei V: Mutational status of IgVH genes in B-cell chronic lymphocytic leukemia and prognosis: percent mutations or antigen-driven selection? Leukemia 2005, 19:1490-1492.
64. Spertini O, Luscinskas FW, Kansas GS, Munro JM, Griffin JD, Gimbrone MA Jr, Tedder TF: Leukocyte adhesion molecule-I (LAM-I, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol 1991, 147:2565-73.
65. Matutes E, Morilla R, Farahat N, Carbonell F, Swansbury J, Dyer M, Catovsky D: Definition of acute biphenotypic leukemia. Haematologica 1997, 82:64-66.
66. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J: International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997, 89:2079-2088.
67. Hamblin TJ, Orchard JA, Gardiner A, Oscier DG, Davis Z, Stevenson FK: Immunoglobulin V genes and CD38 expression in CLL. Blood 2000, 95:2455-7.
68. Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, Schulman P, Vinciguerra VP, Rai K, Rassenti LZ, Kipps TJ, Dighiero G, Schroeder HW Jr, Ferrarini M, Chiorazzi N: Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998, 102:1515-1525.
69. Naylor M, Capra JD: Mutational status of Ig VH genes provides clinically valuable information in B-cell chronic lymphicytic leukemia. Blood 1999, 94:1837-1839.
70. Guarini A, Gaidano G, Mauro FR, Capello D, Mancini F, De Propris MS, Mancini M, Orsini E, Gentile M, Breccia M, Cuneo A, Castoldi G, Foa R: Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood 2003, 102:1035-41.
71. Jelinek DF, Tschumper S, Geyer SM, Bone ND, Dewald GW, Hanson CA, Stenson MJ, Witzig TE, Teffer iA, Kay NE: Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Haematol 2001, 115:854-861.
72. Schroers R, Griesinger F, Trumper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Duhrsen U, Durig J: Combined analysis of ZAP-70 CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 2005, 19:750-758.